News
Lilly falls on slower start for Foundayo versus Wegovy
Sky-high expectations for sales of Eli Lilly's new oral GLP-1 agonist Foundayo have been dented by preliminary sales data from IQVIA.
News
Sun sets out $11.75bn takeover play for Organon
After downplaying persistent rumours for months, Sun Pharma has broken cover with an $11.75 billion takeover agreement for Organon.
Sales & Marketing
Changing Faces: Agency, consultancy, and investor, March 202...
March saw a handful of noteworthy hires in the agency, consultancy, and investor spaces.
News
FDA declines to approve AbbVie's Botox follow-up
AbbVie's bid to bring a rapid and shorter-acting botulinum toxin product to the US market has been knocked back by the FDA.
News
FDA clears first genetic hearing loss gene therapy
Regeneron's Otarmeni is the first gene therapy for congenital hearing loss to be cleared by the FDA, and will be made available for free in the US.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
